Carlisle Companies Incorporated (CSL)

Gross profit margin

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Gross profit US$ in thousands 1,887,700 1,544,000 2,157,400 1,314,700 1,137,400
Revenue US$ in thousands 5,003,600 4,586,900 6,591,900 4,810,300 3,969,900
Gross profit margin 37.73% 33.66% 32.73% 27.33% 28.65%

December 31, 2024 calculation

Gross profit margin = Gross profit ÷ Revenue
= $1,887,700K ÷ $5,003,600K
= 37.73%

The gross profit margin of Carlisle Companies Incorporated has displayed a fluctuating trend over the years based on the data provided.

As of December 31, 2020, the gross profit margin stood at 28.65%, indicating that for every dollar of net sales, the company retained 28.65 cents after accounting for the cost of goods sold.

In the following year, by December 31, 2021, the gross profit margin slightly decreased to 27.33%, which suggests a reduction in profitability relative to net sales.

However, there was a notable improvement in the gross profit margin by December 31, 2022, reaching 32.73%. This uptick signifies an increase in efficiency in production and pricing strategies.

Continuing the positive trend, by December 31, 2023, the gross profit margin further grew to 33.66%, demonstrating sustained improvement in operational performance.

Finally, as of December 31, 2024, the gross profit margin experienced a considerable surge to 37.73%. This significant increase implies enhanced profitability and stronger cost management within the company.

Overall, the trend in Carlisle Companies Incorporated's gross profit margin reflects both fluctuations and improvements over the years, signaling the company's ability to manage costs, optimize production processes, and potentially enhance pricing strategies to boost profitability.


Peer comparison

Dec 31, 2024

Company name
Symbol
Gross profit margin
Carlisle Companies Incorporated
CSL
37.73%
West Pharmaceutical Services Inc
WST
34.51%